Recently added articles from Worldwide Biotech:

BIOTAGE LAUNCHES NEW 24 WELL PYROSEQUENCING SYSTEM.

May 01, 2008 ... Pyrosequencing AB, a subsidiary of Biotage AB, Uppsala, Sweden, has announced the launch of PyroMark(TM)Q24 the latest in the range of Pyrosequencing(R) Systems. This new high-performance platform includes a complete software package for the study of genetic and epigenetic variation of ...

VICAL LICENCEE ANGES MG FILES NDA IN JAPAN FOR COLLATEGENE.

May 01, 2008 ... Vical Incorporated (NASDAQ:VICL), San Diego, Calif., has announced the company's licensee, AnGes MG, Inc., reported submission on of a New Drug Application (NDA) to the Japanese Ministry of Health, Labor and Welfare for its angiogenesis product candidate, Collategene, for treatment of ...

PAREXEL EXPANDS RELATIONSHIP WITH SYNCHRON IN INDIA.

May 01, 2008 ... PAREXEL International Corporation (NASDAQ:PRXL) has announced that it has expanded its minority interest ownership in the clinical pharmacology business of Synchron Research in Ahmedabad, India. The company also announced the sale of a bioanalytical laboratory in Poitiers, France to a ...

NVENTA UNVEILS POSITIVE IMMUNOLOGICAL DATA FROM HSPE7 PHASE 1 TRIAL.

May 01, 2008 ... Nventa Biopharmaceuticals Corporation (TSX:NVN), San Diego. Calif., has announced interim immunological data from the first two cohorts of its ongoing Phase 1 clinical trial of its lead product candidate, HspE7, in patients with cervical intraepithelial neoplasia, or CIN, a precursor to ...